tiprankstipranks
Trending News
More News >
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
PremiumWeekend UpdatesKyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
22d ago
Rocket Pharmaceuticals downgraded at Evercore following patient death in study
Premium
The Fly
Rocket Pharmaceuticals downgraded at Evercore following patient death in study
23d ago
Rocket Pharmaceuticals downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Rocket Pharmaceuticals downgraded to In Line from Outperform at Evercore ISI
23d ago
Rocket Pharmaceuticals downgraded to Sell from Neutral at Goldman Sachs
PremiumThe FlyRocket Pharmaceuticals downgraded to Sell from Neutral at Goldman Sachs
25d ago
Rocket Pharmaceuticals: Buy Rating Affirmed Amid Strategic Adjustments and Financial Resilience
Premium
Ratings
Rocket Pharmaceuticals: Buy Rating Affirmed Amid Strategic Adjustments and Financial Resilience
25d ago
Rocket Pharmaceuticals price target lowered to $17 from $46 at Chardan
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $17 from $46 at Chardan
25d ago
Hold Rating Issued for Rocket Pharmaceuticals Amid Uncertainty Following Clinical Hold on RP-A501 Trial
PremiumRatingsHold Rating Issued for Rocket Pharmaceuticals Amid Uncertainty Following Clinical Hold on RP-A501 Trial
25d ago
Cautious Optimism for Rocket Pharmaceuticals’ RP-A501 Amid Clinical Challenges
Premium
Ratings
Cautious Optimism for Rocket Pharmaceuticals’ RP-A501 Amid Clinical Challenges
25d ago
Rocket Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Rocket Pharmaceuticals downgraded to Market Perform from Outperform at Leerink
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100